1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 CLIA Method
        1.2.3 ELISA Method
    1.3 Market by Application
        1.3.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Screening
        1.3.3 Post-treatment Monitoring
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Prostate-specific Antigen (PSA) Testing Market Perspective (2017-2028)
    2.2 Prostate-specific Antigen (PSA) Testing Growth Trends by Region
        2.2.1 Prostate-specific Antigen (PSA) Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Prostate-specific Antigen (PSA) Testing Historic Market Size by Region (2017-2022)
        2.2.3 Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Region (2023-2028)
    2.3 Prostate-specific Antigen (PSA) Testing Market Dynamics
        2.3.1 Prostate-specific Antigen (PSA) Testing Industry Trends
        2.3.2 Prostate-specific Antigen (PSA) Testing Market Drivers
        2.3.3 Prostate-specific Antigen (PSA) Testing Market Challenges
        2.3.4 Prostate-specific Antigen (PSA) Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Revenue
        3.1.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Revenue (2017-2022)
        3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Prostate-specific Antigen (PSA) Testing Revenue
    3.4 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio
        3.4.1 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prostate-specific Antigen (PSA) Testing Revenue in 2021
    3.5 Prostate-specific Antigen (PSA) Testing Key Players Head office and Area Served
    3.6 Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
    3.7 Date of Enter into Prostate-specific Antigen (PSA) Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate-specific Antigen (PSA) Testing Breakdown Data by Type
    4.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Type (2017-2022)
    4.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2023-2028)
5 Prostate-specific Antigen (PSA) Testing Breakdown Data by Application
    5.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Application (2017-2022)
    5.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Prostate-specific Antigen (PSA) Testing Market Size (2017-2028)
    6.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Type
        6.2.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022)
        6.2.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028)
        6.2.3 North America Prostate-specific Antigen (PSA) Testing Market Share by Type (2017-2028)
    6.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Application
        6.3.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022)
        6.3.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028)
        6.3.3 North America Prostate-specific Antigen (PSA) Testing Market Share by Application (2017-2028)
    6.4 North America Prostate-specific Antigen (PSA) Testing Market Size by Country
        6.4.1 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022)
        6.4.2 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Prostate-specific Antigen (PSA) Testing Market Size (2017-2028)
    7.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type
        7.2.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022)
        7.2.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028)
        7.2.3 Europe Prostate-specific Antigen (PSA) Testing Market Share by Type (2017-2028)
    7.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application
        7.3.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022)
        7.3.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028)
        7.3.3 Europe Prostate-specific Antigen (PSA) Testing Market Share by Application (2017-2028)
    7.4 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country
        7.4.1 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022)
        7.4.2 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size (2017-2028)
    8.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type
        8.2.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Share by Type (2017-2028)
    8.3 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application
        8.3.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Share by Application (2017-2028)
    8.4 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region
        8.4.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size (2017-2028)
    9.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type
        9.2.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022)
        9.2.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028)
        9.2.3 Latin America Prostate-specific Antigen (PSA) Testing Market Share by Type (2017-2028)
    9.3 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application
        9.3.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022)
        9.3.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028)
        9.3.3 Latin America Prostate-specific Antigen (PSA) Testing Market Share by Application (2017-2028)
    9.4 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country
        9.4.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022)
        9.4.2 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size (2017-2028)
    10.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type
        10.2.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Share by Type (2017-2028)
    10.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application
        10.3.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Share by Application (2017-2028)
    10.4 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country
        10.4.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Prostate-specific Antigen (PSA) Testing Introduction
        11.1.4 Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.1.5 Abbott Recent Developments
    11.2 Boston Scientific Corporation
        11.2.1 Boston Scientific Corporation Company Details
        11.2.2 Boston Scientific Corporation Business Overview
        11.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Introduction
        11.2.4 Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.2.5 Boston Scientific Corporation Recent Developments
    11.3 Bayer AG
        11.3.1 Bayer AG Company Details
        11.3.2 Bayer AG Business Overview
        11.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Introduction
        11.3.4 Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.3.5 Bayer AG Recent Developments
    11.4 Siemens Healthcare
        11.4.1 Siemens Healthcare Company Details
        11.4.2 Siemens Healthcare Business Overview
        11.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Introduction
        11.4.4 Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.4.5 Siemens Healthcare Recent Developments
    11.5 DiaSorin
        11.5.1 DiaSorin Company Details
        11.5.2 DiaSorin Business Overview
        11.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Introduction
        11.5.4 DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.5.5 DiaSorin Recent Developments
    11.6 Roche
        11.6.1 Roche Company Details
        11.6.2 Roche Business Overview
        11.6.3 Roche Prostate-specific Antigen (PSA) Testing Introduction
        11.6.4 Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.6.5 Roche Recent Developments
    11.7 Beckman Coulter
        11.7.1 Beckman Coulter Company Details
        11.7.2 Beckman Coulter Business Overview
        11.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Introduction
        11.7.4 Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.7.5 Beckman Coulter Recent Developments
    11.8 PerkinElmer
        11.8.1 PerkinElmer Company Details
        11.8.2 PerkinElmer Business Overview
        11.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Introduction
        11.8.4 PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.8.5 PerkinElmer Recent Developments
    11.9 Tosoh
        11.9.1 Tosoh Company Details
        11.9.2 Tosoh Business Overview
        11.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Introduction
        11.9.4 Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.9.5 Tosoh Recent Developments
    11.10 Ortho Clinical
        11.10.1 Ortho Clinical Company Details
        11.10.2 Ortho Clinical Business Overview
        11.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Introduction
        11.10.4 Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.10.5 Ortho Clinical Recent Developments
    11.11 Fujirebio
        11.11.1 Fujirebio Company Details
        11.11.2 Fujirebio Business Overview
        11.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Introduction
        11.11.4 Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.11.5 Fujirebio Recent Developments
    11.12 Mediwatch
        11.12.1 Mediwatch Company Details
        11.12.2 Mediwatch Business Overview
        11.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Introduction
        11.12.4 Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.12.5 Mediwatch Recent Developments
    11.13 BodiTech
        11.13.1 BodiTech Company Details
        11.13.2 BodiTech Business Overview
        11.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Introduction
        11.13.4 BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.13.5 BodiTech Recent Developments
    11.14 Bristol-Myers Squibb Company
        11.14.1 Bristol-Myers Squibb Company Company Details
        11.14.2 Bristol-Myers Squibb Company Business Overview
        11.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Introduction
        11.14.4 Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.14.5 Bristol-Myers Squibb Company Recent Developments
    11.15 GE Healthcare
        11.15.1 GE Healthcare Company Details
        11.15.2 GE Healthcare Business Overview
        11.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Introduction
        11.15.4 GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.15.5 GE Healthcare Recent Developments
    11.16 Endocare
        11.16.1 Endocare Company Details
        11.16.2 Endocare Business Overview
        11.16.3 Endocare Prostate-specific Antigen (PSA) Testing Introduction
        11.16.4 Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.16.5 Endocare Recent Developments
    11.17 Merck?Co.
        11.17.1 Merck?Co. Company Details
        11.17.2 Merck?Co. Business Overview
        11.17.3 Merck?Co. Prostate-specific Antigen (PSA) Testing Introduction
        11.17.4 Merck?Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.17.5 Merck?Co. Recent Developments
    11.18 Medtronic
        11.18.1 Medtronic Company Details
        11.18.2 Medtronic Business Overview
        11.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Introduction
        11.18.4 Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.18.5 Medtronic Recent Developments
    11.19 Sanofi-Aventis SA
        11.19.1 Sanofi-Aventis SA Company Details
        11.19.2 Sanofi-Aventis SA Business Overview
        11.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Introduction
        11.19.4 Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
        11.19.5 Sanofi-Aventis SA Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of CLIA Method
    Table 3. Key Players of ELISA Method
    Table 4. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Prostate-specific Antigen (PSA) Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Prostate-specific Antigen (PSA) Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Prostate-specific Antigen (PSA) Testing Market Share by Region (2017-2022)
    Table 8. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Prostate-specific Antigen (PSA) Testing Market Share by Region (2023-2028)
    Table 10. Prostate-specific Antigen (PSA) Testing Market Trends
    Table 11. Prostate-specific Antigen (PSA) Testing Market Drivers
    Table 12. Prostate-specific Antigen (PSA) Testing Market Challenges
    Table 13. Prostate-specific Antigen (PSA) Testing Market Restraints
    Table 14. Global Prostate-specific Antigen (PSA) Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Players (2017-2022)
    Table 16. Global Top Prostate-specific Antigen (PSA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2021)
    Table 17. Ranking of Global Top Prostate-specific Antigen (PSA) Testing Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
    Table 21. Date of Enter into Prostate-specific Antigen (PSA) Testing Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2017-2022)
    Table 25. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2023-2028)
    Table 27. Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Application (2017-2022)
    Table 29. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Application (2023-2028)
    Table 31. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Abbott Company Details
    Table 62. Abbott Business Overview
    Table 63. Abbott Prostate-specific Antigen (PSA) Testing Product
    Table 64. Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 65. Abbott Recent Developments
    Table 66. Boston Scientific Corporation Company Details
    Table 67. Boston Scientific Corporation Business Overview
    Table 68. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product
    Table 69. Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 70. Boston Scientific Corporation Recent Developments
    Table 71. Bayer AG Company Details
    Table 72. Bayer AG Business Overview
    Table 73. Bayer AG Prostate-specific Antigen (PSA) Testing Product
    Table 74. Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 75. Bayer AG Recent Developments
    Table 76. Siemens Healthcare Company Details
    Table 77. Siemens Healthcare Business Overview
    Table 78. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product
    Table 79. Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 80. Siemens Healthcare Recent Developments
    Table 81. DiaSorin Company Details
    Table 82. DiaSorin Business Overview
    Table 83. DiaSorin Prostate-specific Antigen (PSA) Testing Product
    Table 84. DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 85. DiaSorin Recent Developments
    Table 86. Roche Company Details
    Table 87. Roche Business Overview
    Table 88. Roche Prostate-specific Antigen (PSA) Testing Product
    Table 89. Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 90. Roche Recent Developments
    Table 91. Beckman Coulter Company Details
    Table 92. Beckman Coulter Business Overview
    Table 93. Beckman Coulter Prostate-specific Antigen (PSA) Testing Product
    Table 94. Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 95. Beckman Coulter Recent Developments
    Table 96. PerkinElmer Company Details
    Table 97. PerkinElmer Business Overview
    Table 98. PerkinElmer Prostate-specific Antigen (PSA) Testing Product
    Table 99. PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 100. PerkinElmer Recent Developments
    Table 101. Tosoh Company Details
    Table 102. Tosoh Business Overview
    Table 103. Tosoh Prostate-specific Antigen (PSA) Testing Product
    Table 104. Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 105. Tosoh Recent Developments
    Table 106. Ortho Clinical Company Details
    Table 107. Ortho Clinical Business Overview
    Table 108. Ortho Clinical Prostate-specific Antigen (PSA) Testing Product
    Table 109. Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 110. Ortho Clinical Recent Developments
    Table 111. Fujirebio Company Details
    Table 112. Fujirebio Business Overview
    Table 113. Fujirebio Prostate-specific Antigen (PSA) Testing Product
    Table 114. Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 115. Fujirebio Recent Developments
    Table 116. Mediwatch Company Details
    Table 117. Mediwatch Business Overview
    Table 118. Mediwatch Prostate-specific Antigen (PSA) Testing Product
    Table 119. Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 120. Mediwatch Recent Developments
    Table 121. BodiTech Company Details
    Table 122. BodiTech Business Overview
    Table 123. BodiTech Prostate-specific Antigen (PSA) Testing Product
    Table 124. BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 125. BodiTech Recent Developments
    Table 126. Bristol-Myers Squibb Company Company Details
    Table 127. Bristol-Myers Squibb Company Business Overview
    Table 128. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product
    Table 129. Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 130. Bristol-Myers Squibb Company Recent Developments
    Table 131. GE Healthcare Company Details
    Table 132. GE Healthcare Business Overview
    Table 133. GE Healthcare Prostate-specific Antigen (PSA) Testing Product
    Table 134. GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 135. GE Healthcare Recent Developments
    Table 136. Endocare Company Details
    Table 137. Endocare Business Overview
    Table 138. Endocare Prostate-specific Antigen (PSA) Testing Product
    Table 139. Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 140. Endocare Recent Developments
    Table 141. Merck?Co. Company Details
    Table 142. Merck?Co. Business Overview
    Table 143. Merck?Co. Prostate-specific Antigen (PSA) Testing Product
    Table 144. Merck?Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 145. Merck?Co. Recent Developments
    Table 146. Medtronic Company Details
    Table 147. Medtronic Business Overview
    Table 148. Medtronic Prostate-specific Antigen (PSA) Testing Product
    Table 149. Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 150. Medtronic Recent Developments
    Table 151. Sanofi-Aventis SA Company Details
    Table 152. Sanofi-Aventis SA Business Overview
    Table 153. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product
    Table 154. Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
    Table 155. Sanofi-Aventis SA Recent Developments
    Table 156. Research Programs/Design for This Report
    Table 157. Key Data Information from Secondary Sources
    Table 158. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate-specific Antigen (PSA) Testing Market Share by Type: 2021 VS 2028
    Figure 2. CLIA Method Features
    Figure 3. ELISA Method Features
    Figure 4. Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2021 VS 2028
    Figure 5. Screening Case Studies
    Figure 6. Post-treatment Monitoring Case Studies
    Figure 7. Other Case Studies
    Figure 8. Prostate-specific Antigen (PSA) Testing Report Years Considered
    Figure 9. Global Prostate-specific Antigen (PSA) Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Prostate-specific Antigen (PSA) Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Prostate-specific Antigen (PSA) Testing Market Share by Region: 2021 VS 2028
    Figure 12. Global Prostate-specific Antigen (PSA) Testing Market Share by Players in 2021
    Figure 13. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue in 2021
    Figure 15. North America Prostate-specific Antigen (PSA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2028)
    Figure 17. North America Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2028)
    Figure 18. North America Prostate-specific Antigen (PSA) Testing Market Size Share by Country (2017-2028)
    Figure 19. United States Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Prostate-specific Antigen (PSA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Prostate-specific Antigen (PSA) Testing Market Size Share by Country (2017-2028)
    Figure 25. Germany Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size Share by Region (2017-2028)
    Figure 35. China Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Prostate-specific Antigen (PSA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Prostate-specific Antigen (PSA) Testing Market Size Share by Country (2017-2028)
    Figure 45. Mexico Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size Share by Country (2017-2028)
    Figure 51. Turkey Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Abbott Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 55. Boston Scientific Corporation Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 56. Bayer AG Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 57. Siemens Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 58. DiaSorin Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 59. Roche Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 60. Beckman Coulter Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 61. PerkinElmer Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 62. Tosoh Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 63. Ortho Clinical Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 64. Fujirebio Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 65. Mediwatch Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 66. BodiTech Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 67. Bristol-Myers Squibb Company Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 68. GE Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 69. Endocare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 70. Merck?Co. Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 71. Medtronic Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 72. Sanofi-Aventis SA Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2017-2022)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed